Interleukin 12 is a heterodimeric cytokine that exhibits potent immunostimulatory effects. It has shown some promise in preclinical and clinical studies but was accompanied by serious systemic toxicity such as flu-like syndromes, a rapid transient leukopenia, elevated liver transaminases, gastrointestinal toxicity, and/or liver dysfunction. Gene therapy with intratumorally injected recombinant adenoviral vectors offers the potential to restrict therapeutic gene expression in the tumor. Here we show that a substantial amount of adenoviral vectors disseminates into the systemic circulation and infects parenchymal organs. We further show that this results in high systemic levels of potentially toxic transgene products. To reduce potential toxicity, we tested an inducible promoter based on the heat shock proteins (hsp70B) and present evidence that high intratumoral levels of a therapeutic transgene can be obtained while systemic expression is reduced to a minimum, increasing the safety of adenovirus-based tumor gene therapy.
|Data di pubblicazione:||2001|
|Titolo:||Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors|
|Autore/i:||Lohr, F; Huang, Q; Hu, K; Dewhirst, Mw; Li, Cy|
|Codice identificativo ISI:||WOS:000172106200045|
|Codice identificativo Scopus:||2-s2.0-0035175933|
|Citazione:||Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors / Lohr, F; Huang, Q; Hu, K; Dewhirst, Mw; Li, Cy. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 7:11(2001), pp. 3625-3628.|
|Tipologia||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris